Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acthar Gel for MS Cognitive Relapses
NCT02290444Phase 3Completed
- Sponsor
- University at Buffalo
- Start
- Aug 2013
- Primary completion
- Nov 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of repository corticotropin injection in multiple sclerosis (MS), sponsored by University at Buffalo. Primary endpoints: Symbol Digit Modalities at Day 90 and Timed 25-foot Walk at Day 90. Started Aug 2013; status: completed.
02
Drugs
repository corticotropin injection
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02290444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02290444.